Better or worse than the original
1Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Journal of Thrombosis and Haemostasis : JTH
|May 13, 2016
Summary
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Pharmaceutical Equivalents
254
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
254
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
236
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
236
Bioequivalence: Overview
2.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.2K
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
222
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
222
FDA Approved Drugs: Changes to Approved Drugs
319
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
319
Transformations of Functions II
235
Transformations in mathematics alter the position or orientation of a function’s graph while preserving its fundamental shape. One important type of transformation is the horizontal shift, which involves modifying the input variable within a function’s equation. This operation affects where outputs occur along the horizontal axis but does not alter the function’s overall structure.A horizontal shift is achieved by replacing the input variable x with either x + c or x - c,...
235


